Axa’s Rocket Lab Corp RKLB Stock Holding History

Axa’s Portfolio RKLB Stock Details RKLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-98,060	Closed	-$1.16M	–	1294
2021 Q1	$1.16M	Buy	+98,060	New	+$1.09M	﹤0.01%	950

Other funds holding RKLB

Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

WHP

Washington Harbour Partners Arlington, Virginia $33.8M AUM 73.62% 1-Year Est. Return

OPU

Omni Partners US Irvine, California $1.95B AUM

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Axa's RKLB Position: Q2 2021 in Review

Axa sold out of Rocket Lab Corp (RKLB) in Q2 2021, closing a stake of 98,060 shares — an estimated $1.16M sold.

Axa first reported a position in RKLB in Q1 2021 and held it in 1 quarter. The position peaked at $1.16M in Q1 2021. 50 funds tracked by Wall St. Rank hold RKLB as of Q2 2021.

Axa reported no remaining Rocket Lab Corp position as of Q2 2021 after selling out during the quarter.
Axa sold 98,060 Rocket Lab Corp shares in Q2 2021, an estimated $1.16M.
Axa first reported a position in Rocket Lab Corp in Q1 2021 and held it in 1 quarter.
Axa's Rocket Lab Corp position peaked at $1.16M in Q1 2021.
50 funds tracked by Wall St. Rank held Rocket Lab Corp as of Q2 2021.

Based on Axa's 13F filing for Q2 2021, filed 13 Aug 2021.